XML 19 R7.htm IDEA: XBRL DOCUMENT v3.22.0.1
CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Common stock
Retained earnings
Retained earnings
Cumulative Effect, Period of Adoption, Adjustment
Accumulated other comprehensive income (loss)
Accumulated other comprehensive income (loss)
Cumulative Effect, Period of Adoption, Adjustment
Beginning balance (in shares) at Dec. 31, 2018     26,995,348        
Beginning balance at Dec. 31, 2018 $ 739,520 $ (548) $ 342,950 $ 412,009 $ 1,532 $ (15,439) $ (2,080)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 17,512     17,512      
Share-based compensation expense (163)   $ (163)        
Common stock issued (in shares)     104,080        
Common stock issued - Option exercise; stock grants 105   $ 105        
Other comprehensive income (loss) 21,840         21,840  
Common stock repurchased (in shares)     (3,208,573)        
Common stock repurchased (98,543)   $ (20,287) (25,521)      
Reclassification to temporary equity 52,735   $ (21,876) (30,859)      
Ending balance (in shares) at Dec. 31, 2019     23,890,855        
Ending balance at Dec. 31, 2019 679,723 $ (3,740) $ 300,729 374,673 $ (3,740) 4,321  
Increase (Decrease) in Temporary Equity [Roll Forward]              
Common stock repurchased (52,735)            
Ending balance at Dec. 31, 2019 0            
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 79,990     79,990      
Share-based compensation expense 2,693   $ 2,693        
Common stock issued (in shares)     140,386        
Common stock issued - Option exercise; stock grants 782   $ 782        
Other comprehensive income (loss) 31,036         31,036  
Dividends declared ($1.00 per share) (13,865)     (13,865)      
Common stock repurchased (in shares)     (2,234,337)        
Common stock repurchased $ (58,869)   $ (25,699) (33,170)      
Ending balance (in shares) at Dec. 31, 2020 21,796,904   21,796,904        
Ending balance at Dec. 31, 2020 $ 717,750   $ 278,505 403,888   35,357  
Ending balance at Dec. 31, 2020 0            
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 115,422     115,422      
Share-based compensation expense 3,398   $ 3,398        
Common stock issued (in shares)     260,267        
Common stock issued - Option exercise; stock grants 2,418   $ 2,418        
Other comprehensive income (loss) (14,217)         (14,217)  
Dividends declared ($1.00 per share) (21,338)     (21,338)      
Common stock repurchased (in shares)     (1,971,835)        
Common stock repurchased $ (88,094)   $ (34,465) (53,629)      
Ending balance (in shares) at Dec. 31, 2021 20,085,336   20,085,336        
Ending balance at Dec. 31, 2021 $ 715,339   $ 249,856 $ 444,343   $ 21,140  
Ending balance at Dec. 31, 2021 $ 0